12,115 followers
RT @FrontOncology: New research: Case report: Response to Savolitinib/EGFR-TKI combination in NSCLC patients harboring concurrent primary M…
RT @FrontOncology: New research: Case report: Response to Savolitinib/EGFR-TKI combination in NSCLC patients harboring concurrent primary M…
New research: Case report: Response to Savolitinib/EGFR-TKI combination in NSCLC patients harboring concurrent primary MET amplification/overexpression and EGFR mutation: Lung cancer is the leading cause of cancer death, accounting for… https://t.co/pZsWmz